Carol Fabian, Md

This small, early study tested whether a 6-month course of a drug combination (bazedoxifene plus estrogen), already approved for hot flashes, could change breast tissue in a way that might lower cancer risk. It involved 16 women experiencing menopause symptoms who were already at…